Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Abern

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Urologic Oncology|March 1, 2025
Re: Hera et al. impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombusAlireza Ghoreifi, Michael Abern
European Urology|December 4, 2014
Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?Aaron Ovadia, Michael Abern
Urology|January 4, 2021
EDITORIAL COMMENTHari Vigneswaran, Michael Abern
The Journal of Urology|May 13, 2025
Reply: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal ConduitAlireza Ghoreifi, Ankeet Shah, Michael Abern
Oncotargets and Therapy|June 22, 2011
An update on TroVax for the treatment of progressive castration-resistant prostate cancerMichael Abern, Howard L Kaufman, Kalyan Latchamsetty
The Journal of Urology|January 11, 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. LetterRand N Wilcox Vanden Berg, Michael Abern
International Journal of Surgical Pathology|December 20, 2014
Cystic nephroma/mixed epithelial stromal tumor: a benign neoplasm with potential for recurrenceBelinda L Sun, Michael Abern, Steven Garzon, et al.
Urology|September 23, 2019
Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy WorkshopShaan Setia, Carol Feng, Christopher Coogan, et al.
Urology|May 9, 2024
Radiation-induced Sarcoma of the Prostate After Treatment for RhabdomyosarcomaDiana A Aponte-Colon, Austin Creviston, Michael Abern, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2023
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A reviewRand N Wilcox Vanden Berg, Thomas Zilli, Vérane Achard, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Urologic Oncology|March 1, 2025
Re: Hera et al. impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombusAlireza Ghoreifi, Michael Abern
European Urology|December 4, 2014
Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?Aaron Ovadia, Michael Abern
Urology|January 4, 2021
EDITORIAL COMMENTHari Vigneswaran, Michael Abern
The Journal of Urology|May 13, 2025
Reply: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal ConduitAlireza Ghoreifi, Ankeet Shah, Michael Abern
Oncotargets and Therapy|June 22, 2011
An update on TroVax for the treatment of progressive castration-resistant prostate cancerMichael Abern, Howard L Kaufman, Kalyan Latchamsetty
The Journal of Urology|January 11, 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. LetterRand N Wilcox Vanden Berg, Michael Abern
International Journal of Surgical Pathology|December 20, 2014
Cystic nephroma/mixed epithelial stromal tumor: a benign neoplasm with potential for recurrenceBelinda L Sun, Michael Abern, Steven Garzon, et al.
Urology|September 23, 2019
Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy WorkshopShaan Setia, Carol Feng, Christopher Coogan, et al.
Urology|May 9, 2024
Radiation-induced Sarcoma of the Prostate After Treatment for RhabdomyosarcomaDiana A Aponte-Colon, Austin Creviston, Michael Abern, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2023
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A reviewRand N Wilcox Vanden Berg, Thomas Zilli, Vérane Achard, et al.
Pageof 4